Atopic Dermatitis Research Trial for Adults (36 Weeks)

Adults aged 18-75 years old with chronic atopic dermatitis (AD) present for at least 1 year, may qualify to participate. Individuals must have moderate to severe, active, and symptomatic AD with involvement of 10% or more body surface area. A history of poor response to treatment for AD with topical medications, unless topical treatments are otherwise medically inadvisable, or has needed systemic therapy for control of their disease, is also required. Must be willing to apply topical emollient twice daily throughout the study.

Participants will receive investigational medication (active study drug) or placebo, via subcutaneous injection. Study medication and study-related procedures will be provided at no cost. Reimbursement for study-related expenses will also be provided.

Study participation will last about 36 weeks and involve about 20 visits to the study centre.

Call the study centre near you, or register now.

Learn more about
Atopic Dermatitis
Register Now!

Participating Locations

AR

  • Sorry no locations are available in this country.

AU

  • Sorry no locations are available in this country.

CL

  • Sorry no locations are available in this country.

MX

  • Sorry no locations are available in this country.

US

  • Sorry no locations are available in this country.

Register for
Active Studies!

Register

All information about you will be kept confidential.

If there are no active studies for your condition, we will keep your information and contact you when a new study starts in your area.

By registering you are consenting to the terms and conditions of our privacy policy.

Find the clinic near you:

Why Take Part In a Clinical Study?

Regulatory agencies like Health Canada, Australia's Therapeutic Goods Administration and the FDA require that Clinical Research Trials be conducted in order to develop new treatments, preventions and devices for diseases or conditions. Clinical Research Trials are also referred to as Clinical Studies or Clinical Trials. read more